Pawlicki Raymond 4
4 · BIOGEN IDEC INC. · Filed Feb 7, 2013
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Pawlicki Raymond
SVP, Chief Information Officer
Transactions
- Sale
Common Stock
2013-02-06$165.55/sh−10,000$1,655,500→ 7,652.711 total - Exercise/Conversion
Common Stock
2013-02-06$49.65/sh+10,000$496,500→ 17,652.711 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-02-06−10,000→ 7,855 totalExercise: $49.65Exp: 2019-02-24→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock options vest in four (4) equal annual installments commencing one year after the grant date of 02/24/09.